Covered recipient · General Payments record
SUSHAMA A SCALERA
Allopathic & Osteopathic Physicians Emergency Medicine
General Payments · PY2021–2024
$2,322,598.18
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $950,304.09 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | $488,887.50 | 10 |
| Immunocore Limited | $461,416.59 | 13 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $61,337.50 | 02/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125844137 | CMS |
| Alnylam Pharmaceuticals Inc. | $36,062.50 | 02/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125844139 | CMS |
| Alnylam Pharmaceuticals Inc. | $62,737.50 | 03/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125844143 | CMS |
| Alnylam Pharmaceuticals Inc. | $57,250.00 | 05/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125844165 | CMS |
| Alnylam Pharmaceuticals Inc. | $43,712.50 | 05/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125844163 | CMS |
| Alnylam Pharmaceuticals Inc. | $43,050.00 | 06/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125844177 | CMS |
| Alnylam Pharmaceuticals Inc. | $58,987.50 | 08/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125844195 | CMS |
| Alnylam Pharmaceuticals Inc. | $43,125.00 | 09/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125844209 | CMS |
| Alnylam Pharmaceuticals Inc. | $50,387.50 | 10/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125844225 | CMS |
| Alnylam Pharmaceuticals Inc. | $32,237.50 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125844223 | CMS |
| Immunocore Limited | $37,533.80 | 01/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103096697 | CMS |
| Immunocore Limited | $24,047.79 | 01/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103096695 | CMS |
| Immunocore Limited | $27,652.50 | 02/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098317 | CMS |
| Immunocore Limited | $33,345.00 | 04/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098321 | CMS |
| Immunocore Limited | $31,612.50 | 05/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098267 | CMS |
| Immunocore Limited | $36,480.00 | 05/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098269 | CMS |
| Immunocore Limited | $39,202.50 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098275 | CMS |
| Immunocore Limited | $27,157.50 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098277 | CMS |
| Immunocore Limited | $35,077.50 | 09/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098279 | CMS |
| Immunocore Limited | $32,437.50 | 10/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098281 | CMS |
| Immunocore Limited | $47,602.50 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098283 | CMS |
| Immunocore Limited | $50,655.00 | 11/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098299 | CMS |
| Immunocore Limited | $38,612.50 | 12/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103098313 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.